Last updated: May 7, 2024
Sponsor: Beijing Friendship Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Post-operative Nausea And Vomiting
Vomiting
Treatment
Opioid Anesthetics (sufentanil and remifentanil)
Opioid-free Analgesics (esketamine, dexmedetomidine)
Clinical Study ID
NCT06305221
opioid-free analgesia
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing elective laparoscopic sleeve gastrectomy
- ASAA I or grade;
- volunteered in this trial and signed informed consent; ④ age 18-65 years; ⑤BMI> 30kg / m2.
Exclusion
Exclusion Criteria:
- chronic pain;
- severe liver dysfunction (total bilirubin 2 mg dl-1);
- severe renal dysfunction (glomerular filtration rate 60ml min-1 1.73m-2);
- pregnancy or lactation;
- preoperative heart rate <50 beats / min, sick sinus syndrome, severe heart block; -dementia or significant neurological disorders (such as stroke, epilepsy,intracranial tumors, PD, etc.);
- history of alcohol or drug abuse
Study Design
Total Participants: 76
Treatment Group(s): 2
Primary Treatment: Opioid Anesthetics (sufentanil and remifentanil)
Phase:
Study Start date:
March 09, 2024
Estimated Completion Date:
March 31, 2025
Connect with a study center
bijia Song
Beijing,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.